Diabetes mellitus Samples
Central BioHub offers human serum samples from patients with Diabetes mellitus like Type 2 diabetes mellitus or Unspecified diabetes mellitus. You can use the filter functions to specify your desired products by laboratory parameters and donor specifications like ethnicity, BMI, medication, age and gender. Procurement takes place from consented donors under strict ethical standards. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact us.
712 Products
Human Serum - Cross-reactive carbohydrate determina... - E11.90 - Self-reported Healthy
- Donor:
- Gender: Female Age: 50 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- L-thyroxine
- Parameter:
- Cross-reactive carbohydrate determinants (CCD) Hematokrit Hemoglobin (Hb) SIgE Italian/Mediterranean/Funeral cypress (t23) SIgE Almond (f20) SIgE Alternaria alternata (m6) SIgE Apple (f49) SIgE Apricot (f237) SIgE Aspergillus fumigatus (m3) SIgE Beef (f27) ...
Donor:
- Gender:
- Female
- Age:
- 50 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 52 kg/m²
- Blood type:
- B
- Rhesus factor:
- not specified
- Weight:
- 160 kg
- Height:
- 175 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- E11.90
Medication:
- L-thyroxine (Dosages: 100not specified)
- Rocaltrol (Dosages: 50not specified)
- Victoza
- calcium (Dosages: 500not specified)
- metformin
- none
- risedronic acid
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Cross-reactive carbohydrate determinants (CCD) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
|
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| Hematokrit |
Qual:
Quant: 39 %
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hemoglobin (Hb) |
Qual:
Quant: 13.2 g/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| SIgE Italian/Mediterranean/Funeral cypress (t23) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Almond (f20) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Alternaria alternata (m6) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Apple (f49) |
Qual:
Quant: 1.7 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:2 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Apricot (f237) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Aspergillus fumigatus (m3) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Beef (f27) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Birch (t3) |
Qual:
Quant: 33 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:4 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Carrot (f31) |
Qual:
Quant: 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:1 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Cat dander (e1) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Celery (f85) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Cladosporium herbarum (m2) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Cockroach, German (i6) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Cocksfoot (g3) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Common ragweed (w1) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Common wasp (Yellow jacket) (i3) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Crab (f23) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Cultivated rye (g12) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Dermatophagoides farinae (d2) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Dermatophagoides pteronyssinus (d1) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Egg white (f1) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Egg yolk (f75) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Fish (cod) (f3) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Greer Labs., Inc. (h1) |
Qual:
Quant: 15.4 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:3 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Grey alder (t2) |
Qual:
Quant: 45 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:4 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Hazel (t4) |
Qual:
Quant: 10.5 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:3 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Hazel nut (f17) |
Qual:
Quant: 1.4 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:2 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Honey bee (i1) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Horse dander (e3) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Kiwi (f84) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Latex (k82) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Milk (f2) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Mugwort (w6) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Mutton (f88) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Oak (t7) |
Qual:
Quant: 13.4 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:3 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Peanut (f13) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Penicillium chrysogenum (P. notatum) (m1) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Plantain, Ribwort (w9) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Potato (f35) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Rice (f9) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Rye (f5) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Sesame seed (f10) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Shrimp (f24) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Soybean (f14) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Sweet vernal grass (g1) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Timothy grass (g6) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Tomato (f25) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Wheat flour (f4) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE Yeast (f45) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE dog (e2) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE nBos d 4 alpha-lactalbumin, Milk (f76) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE nBos d 5 beta-lactoglobulin, Milk (f77) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE nBos d 6 BSA, Cow (e204) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| SIgE nBos d 8 Casein, Milk (f78) |
Qual:
Quant: < 0.35 kU/L
Source: this donation
Remarks: CAP/RAST/EAST-class:0 |
< 0.35 kU/L
|
Method: Immunoblot System: EUROLineScan-Programm EUROIMMUN AG |
| Total IgE |
Qual:
Quant: 43 IU/mL
Source: this donation
|
< 25.00 IU/mL
Remarks: borderline: 25,00 - 100,00, positive: > 100,00 |
System: Cobas 8000 e602 Roche |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH193529
1 mL (€37.50)
Human Serum - Anti-Glutamate Decarboxylase (GAD), A... - E05.0
- Donor:
- Gender: Male Age: 43
- Diagnosed disease:
- E10.01 - Type 1 diabetes mellitus with ketoacidosis
- Medication:
- Kreon
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyroglobulin (Tg) Thyrotropin (TSH) Thyroxine (FT4) Triglycerides Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 43 Years
- BMI:
- 36 kg/m²
- Weight:
- 121 kg
- Height:
- 183 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Thyrotoxicosis with diffuse goitre [E05.0]
- Type 1 diabetes mellitus with ketoacidosis [E10.01]
Medication:
- Kreon
- Lantus
- Novorapid
- amlodipine
- atorvastatin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual:
Quant: < 0.60 U/mL
Source: this donation
|
< 0.90 U/mL
|
Method: RIA (Radioimmunoassay) System: LKB 147 Gamma Counter Berthold Technologies |
| Anti-Thyroglobulin (aTg / TAK) |
Qual:
Quant: < 50.00 IU/mL
Source: this donation
|
< 100 IU/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 39.9 kU/L
Source: this donation
|
< 35.00 kU/L
|
Method: CLIA (Chemiluminescence Immuno Assay) System: Immulite Siemens |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 77 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 0.8 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroglobulin (Tg) |
Qual:
Quant: 3.01 ng/mL
Source: this donation
|
2.00 - 70.00 ng/mL
|
Method: LIA (Luminescence Immuno Assay) System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.57 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 13.6 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triglycerides |
Qual:
Quant: 1.02 mmol/L
Source: this donation
|
< 2.25 mmol/L
|
Method: not specified System: not specified Beckman Coulter |
| Triiodothyronine (FT3) |
Qual:
Quant: 4 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH180212
183 mL (€6,862.50)
Human Sodium heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Sodium heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.3 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.4 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.3 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH147121
1 mL (€37.50)
Human Li-heparin plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Li-heparin plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.3 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.4 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.3 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH147118
1 mL (€37.50)
Human K3EDTA plasma - Anti-Thyroid peroxidase (aTPO / MAK),... - E03.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Euthyrox
- Parameter:
- Anti-Thyroid peroxidase (aTPO / MAK) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 74.5 kg
- Height:
- 168 cm
Sample:
- Matrix:
- K3EDTA plasma
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Thyrotoxicosis with diffuse goitre [E05.0]
- E11.90
- hypertension
- hypoparathyroidism - partial (not specified)
Medication:
- Euthyrox (Dosages: 112µg)
- Lantus (active agent: insulin glargin)
- Metoprolol
- Novorapid (active agent: insulin aspart)
- simvastatine
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 16.3 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: 24.27 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 0.73 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 18.4 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 2.3 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH147115
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 63 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- insulin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 63 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 56 kg/m²
- Weight:
- 152 kg
- Height:
- 165 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (not specified)
- hypertension
- sleep apnoea
Medication:
- insulin
- metformin
Therapy:
- cardiac valve replacement
- thyroid surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH146089
1 mL (€37.50)
Human Serum - Anti-Glutamate Decarboxylase (GAD), A... - E03.9
- Donor:
- Gender: Male Age: 35 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.9 - Type 1 diabetes mellitus without complications
- Medication:
- Lantus
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Insulin (IAA) Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2) TSH Receptor Antibodies (TRAb) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 35 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 24 kg/m²
- Weight:
- 74 kg
- Height:
- 177 cm
Sample:
- Matrix:
- Serum
- Condition:
- slightly turbid
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- Type 1 diabetes mellitus without complications [E10.9]
- hyperprolactinaemia
Medication:
- Lantus (active agent: insulin glargin)
- Novorapid (active agent: insulin aspart)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual:
Quant: 106.1 U/mL
Source: this donation
|
< 1.00 U/mL
Remarks: reference range changed, before: < 0,90 |
Method: RIA (Radioimmunoassay) System: LKB 147 Gamma Counter Berthold Technologies |
| Anti-Insulin (IAA) |
Qual:
Quant: 0.06 U/mL
Source: this donation
|
< 0.40 U/mL
|
Method: RIA (Radioimmunoassay) System: not specified not specified |
| Anti-Protein Tyrosine Phosphatase-like Protein IA-2 Antibodies (IA-2) |
Qual:
Quant: 80.9 U/mL
Source: this donation
|
< 10.00 U/mL
|
Method: ELISA (Enzyme Linked Immunosorbent Assay) System: Tecan Sunrise Photometer Tecan Trading AG |
| TSH Receptor Antibodies (TRAb) |
Qual:
Quant: < 0.30 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 2.26 mU/L
Source: this donation
Remarks: basal |
0.35 - 4.94 mU/L
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Thyrotropin (TSH) |
Qual:
Quant: 5.33 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 12.9 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 3.7 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH192737
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 83 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- ASS
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 83 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 75 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (not specified)
Medication:
- ASS
- Metoprolol
- Ramipril
- amlodipine
- no incretin mimetics
- no insulin
- none
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH169795
1 mL (€37.50)
Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 41 kg/m²
- Weight:
- 112 kg
- Height:
- 165 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
- thyroid disease
Medication:
- L-thyroxine
- Toujeo (specific information from donor: Toujeo 300 U/ml)
- atorvastatin
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Blood sugar (fasting) |
Qual:
Quant: 135 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.6 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165497
1 mL (€37.50)
Human Serum - Blood glucose (postprandial), Glycosy... - E78.2
- Donor:
- Gender: Female Age: 41 Ethnic group: Not specified
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Prednisolon
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 41 Years
- Ethnic group:
- Not specified
- BMI:
- 32 kg/m²
- Weight:
- 84 kg
- Height:
- 162 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Mixed hyperlipidaemia [E78.2]
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Prednisolon (specific information from donor: Prednisolon 5 mg)
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 173 mg/dl
Source: this donation
|
|
Method: not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.1 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.3 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165459
1 mL (€37.50)
Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9
- Donor:
- Gender: Female Age: 74 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- incretin mimetics
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 74 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 29 kg/m²
- Weight:
- 68.8 kg
- Height:
- 155 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
- hypothyroidism
Medication:
- incretin mimetics
- metformin
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Blood sugar (fasting) |
Qual:
Quant: 78 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.3 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165492
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Female Age: 72 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- Candesartan
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 72 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 84 kg
- Height:
- 168 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90]
- hypertension
- polyarthritis
Medication:
- Candesartan
- amlodipine
- metfomin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.7 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165508
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9
- Donor:
- Gender: Female Age: 50 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Metex
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 50 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 31 kg/m²
- Weight:
- 90 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
- rheumatism - 1 (not specified)
- thyroid disease - 1 (not specified)
Medication:
- Metex
- Novorapid
- Protaphan
- insulin
- metformin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.3 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165636
1 mL (€37.50)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Female Age: 65 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- metformin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 65 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 33 kg/m²
- Weight:
- 85 kg
- Height:
- 161 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- asthma
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- metformin
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Blood glucose (postprandial) |
Qual:
Quant: 132 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 5.7 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165494
1 mL (€37.50)
Human Serum - Anti-Thyroglobulin (aTg / TAK), Anti-... - E06.3
- Donor:
- Gender: Male Age: 18 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.90
- Medication:
- Levemir
- Parameter:
- Anti-Thyroglobulin (aTg / TAK) Anti-Thyroid peroxidase (aTPO / MAK) Thyrotropin (TSH) Thyroxine (FT4) Triiodothyronine (FT3)
Donor:
- Gender:
- Male
- Age:
- 18 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 83.5 kg
- Height:
- 173 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Autoimmune thyroiditis [E06.3]
- E10.90
- vitamin D deficiency
Medication:
- Levemir
- Vigantoletten (specific information from donor: Vigantolette 500 IU)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Thyroglobulin (aTg / TAK) |
Qual:
Quant: 230.9 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Anti-Thyroid peroxidase (aTPO / MAK) |
Qual:
Quant: 149.6 IU/mL
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyrotropin (TSH) |
Qual:
Quant: 2.98 mIU/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Thyroxine (FT4) |
Qual:
Quant: 9.8 pmol/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Triiodothyronine (FT3) |
Qual:
Quant: 6.85 pmol/L
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH167019
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Female Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- L-thyroxine
- Parameter:
- Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
- Gender:
- Female
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 18 kg/m²
- Weight:
- 52 kg
- Height:
- 160 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- E11.90
- atrial fibrillation
Medication:
- L-thyroxine (specific information from donor: L-thyroxine 100)
- metformin
- no insulin
Therapy:
- surgery
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis C Virus ribonucleic acid (HCV-RNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: qPCR (Real-Time Quantitative PCR) System: Cobas Ampliprep/Cobas TaqMan Roche |
| Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: PCR (Polymerase Chain Reaction) System: Cobas Ampliprep/Cobas TaqMan Roche |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165346
1 mL (€75.00)
Human Serum - E11.21
- Donor:
- Gender: Female Age: 76 Ethnic group: Not specified
- Diagnosed disease:
- E11.21
- Medication:
- Januvia
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 76 Years
- Ethnic group:
- Not specified
- BMI:
- 27 kg/m²
- Weight:
- 68 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.21]
Medication:
- Januvia (specific information from donor: Januvia 50 mg)
- Losartan (specific information from donor: Losartan 100 mg)
- Prednisolon (specific information from donor: Prednisolon 1 mg)
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165523
1 mL (€37.50)
Human Serum - Blood glucose, Glycosylated hemoglobi... - E11.9
- Donor:
- Gender: Male Age: 73 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Lantus
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 73 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 24 kg/m²
- Weight:
- 71 kg
- Height:
- 172 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Lantus
- atorvastatin (specific information from donor: atorvastatin 20)
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose |
Qual:
Quant: < 6.5 %
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.1 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165577
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9
- Donor:
- Gender: Male Age: 49 Ethnic group: Asian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- L-thyroxine
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 49 Years
- Ethnic group:
- Asian
- BMI:
- 26 kg/m²
- Weight:
- 99 kg
- Height:
- 196 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- L-thyroxine
- Victoza
- insulin
- metformin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.2 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165485
1 mL (€37.50)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Female Age: 60 Ethnic group: Not specified
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- metformin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 60 Years
- Ethnic group:
- Not specified
- BMI:
- 30 kg/m²
- Weight:
- 79 kg
- Height:
- 162 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 107 mg/dl
Source: this donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.3 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165575
1 mL (€37.50)
Human Serum - Blood glucose (postprandial), Glycosy... - E11.9
- Donor:
- Gender: Female Age: 73 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Lantus
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 73 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 38 kg/m²
- Weight:
- 71.5 kg
- Height:
- 138 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
- Lantus
- Liprolog
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Blood glucose (postprandial) |
Qual:
Quant: 149 mg/dl
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 7.2 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH170850
1 mL (€37.50)
Human Serum - Anti-Glutamate Decarboxylase (GAD), A... - E10.90
- Donor:
- Gender: Male Age: 28 Ethnic group: European/Caucasian
- Diagnosed disease:
- E10.90 - type 1 (reliable diagnosis)
- Medication:
- Humalog
- Parameter:
- Anti-Glutamate Decarboxylase (GAD) Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Anti-Zinc transporter 8 Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 28 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 89 kg
- Height:
- 186 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E10.90] - type 1 (reliable diagnosis)
Medication:
- Humalog (specific information from donor: Humalog 20 IU/d)
- Levemir (specific information from donor: Levemir 12 IU/d)
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Glutamate Decarboxylase (GAD) |
Qual:
Quant: < 0.70 U/mL
Source: this donation
|
< 1.00 U/mL
Remarks: reference range has changed (before: < 0,90) |
Method: RIA (Radioimmunoassay) System: LKB 147 Gamma Counter Berthold Technologies |
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Anti-Zinc transporter 8 |
Qual:
Quant: 85.9 U/mL
Source: this donation
|
< 15.00 U/mL
|
Method: EIA (Enzyme Immuno Assay) System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH216408
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Male Age: 69 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (reliable diagnosis)
- Medication:
- metformin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 69 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 28 kg/m²
- Weight:
- 83 kg
- Height:
- 172 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
- metformin
- no incretin mimetics
- no insulin
Therapy:
- implant
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.2 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH166126
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90
- Donor:
- Gender: Female Age: 54 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (reliable diagnosis)
- Medication:
- no incretin mimetics
- Parameter:
- Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 54 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 29 kg/m²
- Weight:
- 78 kg
- Height:
- 164 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Anamneses:
- dietary change diet (information given at the time of donation)
Diseases:
- diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
- no incretin mimetics
- no insulin
Therapy:
- gastric bypass
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.9 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH198043
1 mL (€75.00)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E03.9
- Donor:
- Gender: Female Age: 65 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (reliable diagnosis)
- Medication:
- Byetta
- Parameter:
- Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
- Gender:
- Female
- Age:
- 65 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 46 kg/m²
- Weight:
- 133 kg
- Height:
- 170 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hypothyroidism, unspecified [E03.9]
- I10.90
- J44.89
- Asthma, unspecified [J45.9]
- diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
- Byetta (Dosages: 10µg, active agent: exenatide)
- L-thyroxine (Dosages: 50not specified)
- Nebivolol
- Siofor
- Valsartan
- amlodipine
- atorvastatin
- insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.8 not specified
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH220252
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E78.2
- Donor:
- Gender: Male Age: 58 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- metformin
- Parameter:
- Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 58 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 26 kg/m²
- Weight:
- 94 kg
- Height:
- 190 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Mixed hyperlipidaemia [E78.2]
- bronchial asthma
- diabetes mellitus [E11.90] - type 2 (not specified)
- postthrombotic syndrome
- renal insufficiency - grade III (not specified)
Medication:
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.9 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165472
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Male Age: 75 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90 - type 2 (not specified)
- Medication:
- Gliptin
- Parameter:
- 0 Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Male
- Age:
- 75 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 31 kg/m²
- Weight:
- 95 kg
- Height:
- 176 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- chronic obstructive pulmonary disease (COPD)
- diabetes mellitus [E11.90] - type 2 (not specified)
- hyperlipoproteinaemia
- hypertension
- polyneuropathy
Medication:
- Gliptin
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| 0 |
Qual:
Quant:
Source:
|
|
|
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH214272
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.
- Donor:
- Gender: Female Age: 70 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11. - type 2 (not specified)
- Medication:
- Insulin
- Parameter:
- Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
- Gender:
- Female
- Age:
- 70 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 79 kg
- Height:
- 158 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- diabetes mellitus [E11.] - type 2 (not specified)
- fibromyalgia
- hepatic cirrhosis - early stadium (not specified)
- hepatic fibrosis
- hypertension
- spinal stenosis
Medication:
- Insulin
- no incretin mimetics
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Anti-Hepatitis C Virus (HCV) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.1 %
Source:
|
not specified not specified
|
Method: not specified System: not specified not specified |
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH169862
1 mL (€37.50)
Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9
- Donor:
- Gender: Female Age: 57 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
- Medication:
- Irbesartan
- Parameter:
- Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
- Gender:
- Female
- Age:
- 57 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 32 kg/m²
- Weight:
- 85 kg
- Height:
- 163 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- Hashimotos thyroiditis
- Mnires disease
- diabetes mellitus [E11.9] - type 2 (not specified)
- hyperlipidaemia
- hypertension
Medication:
- Irbesartan
- L-thyroxine (Dosages: 125not specified)
- metformin
- no incretin mimetics
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Glycosylated hemoglobin (HbA1, HbA1c) |
Qual:
Quant: 6.5 %
Source: previous donation
|
not specified not specified
|
Method: not specified System: not specified not specified |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH170899
1 mL (€37.50)
Human Serum - E11.90
- Donor:
- Gender: Male Age: 49 Ethnic group: European/Caucasian
- Diagnosed disease:
- E11.90
- Medication:
- allopurinol
- Parameter:
- Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
- Gender:
- Male
- Age:
- 49 Years
- Ethnic group:
- European/Caucasian
- BMI:
- 30 kg/m²
- Weight:
- 95 kg
- Height:
- 175 cm
Sample:
- Matrix:
- Serum
- Condition:
- perfect
- Freeze-Thaw-Cycle:
- 0
Diseases:
- E11.90
- Gilberts disease
- fibromyalgia
- gout
- hypertension
Medication:
- allopurinol (specifc information from donor: allopurinol 150 mg)
- lisinopril (specific information from donor: lisinopril 5 mg)
- metformin (specific information from donor: metformin 2000 mg)
- no insulin
| Parameter | Result | Ref. / Cut-Off | Measuring Information |
|---|---|---|---|
| Hepatitis B Virus surface Antigen (HBsAg) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay) System: Architect i 2000 sr Abbott Diagnostics |
| Hepatitis C Virus ribonucleic acid (HCV-RNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: qPCR (Real-Time Quantitative PCR) System: Cobas Ampliprep/Cobas TaqMan Roche |
| Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA) |
Qual: negative
Quant:
Source: this donation
|
negative
|
Method: PCR (Polymerase Chain Reaction) System: Cobas Ampliprep/Cobas TaqMan Roche |
Disclaimer
- All products are for research or manufacturing purposes only and are not for direct therapeutic or diagnostic use in human or animals.
- Biospecimens should be treated as potentially infectious. Each specimen is intended for use only in by qualified professionals who will safely handle and dispose of the products they receive.
- Import permit for biological substances must be present for purchase.
- This sample is not for molecular genetic studies.
CBH165342
1 mL (€75.00)
